Peter Knapp and Suzy Ker review a recent study from Finland, which suggests that women with schizophrenia who take prolactin-increasing antipsychotics for at least five years, have an increased risk of developing breast cancer.
[read the full story...]
Rachel Symons reviews a recent Italian study which finds that autism spectrum disorder is still commonly undiagnosed and misdiagnosed in adults.
[read the full story...]
Manas Dave takes a look at this review aiming to identify the potential risk factors associated with the development of oral mucositis in paediatric patients. While a range of risk factos are higlighted it is worth noting that 80-100% of all children having chemotherapy experience some degree of mucositis.
[read the full story...]
In her debut blog, Shania Lorenz summarises a qualitative research study that looks at the experiences of women with eating disorders and autism, their parents and health professionals.
[read the full story...]
In her debut blog, Anjana Greedharee reviews a co-produced, participatory qualitative study on the experiences of living with mental health problems during the COVID-19 pandemic in the UK.
[read the full story...]
In her debut blog, Aneta Zarska reviews a cohort study which looks at the links between death from COVID-19 and a range of mental health conditions, including schizophrenia, depression and anxiety.
[read the full story...]
Elena Marcus summarises a recent systematic review on quality of life in adults with multiple sclerosis, which identified a range of promising psychological interventions for improving quality of life.
[read the full story...]
Lydia Poole reviews a recent Canadian study examining depression as a risk factor for physical illness and multimorbidity in a cohort with no prior comorbidity.
[read the full story...]
“There are many other ways to get our patients better than prescribing and talking.”
Shuichi Suetani reviews a recently published textbook: The Maudsley Practice Guidelines for Physical Health Conditions in Psychiatry.
[read the full story...]
Douglas Badenoch appraises an up-to-date systematic review and decision pathway for the drug treatment of ADHD symptoms in young people with autism spectrum disorder.
Follow #CAMHScampfire on Twitter at 5pm BST on Tuesday 25th May for an online journal club discussing this paper. Or sign up now to join the free webinar hosted by ACAMH.
[read the full story...]
